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 Abstract  
Gastric cancer or stomach cancer represents a major public health problem in the contiguous 
United States and in Alaska. Stomach cancer is the fourth most common malignancy and the 
second most common cause of cancer-related deaths throughout the world. A retrospective study 
of gastric cancer cases from 1996 to 2011 was undertaken and data were extracted from the 
Alaska Cancer Registry where cases are consistently recorded and centralized. Data were 
analyzed using the National Cancer Institute’s SEER* Stat statistical software (version 8.1.5). 
The goal of the project was to provide a detailed epidemiologic descriptive analysis of gastric 
cancer to better inform health professionals, the public and to provide additional resources for 
future research. Results showed that gastric cancer incidence rates in Alaska are significantly 
higher than the rest of the nation. Alaska Natives and American Indians in Alaska have the 
highest rate of gastric cancer than all races/ethnicities combined. Males have a risk prevalence of 
gastric cancer that is twice that for females. The Alaska Native male and Asian/Pacific Islander 
male gastric cancer incidence rates are much higher than males from other races. In addition, 
Southeast Alaska Natives’ incidence rates are lower than rates for non-Southeast Alaska Natives. 
Based on the findings, study recommendations include the following: 1) Health education 
campaigns for at risk-groups; 2) Making health care services available; 3) Education of local 
health community workers and health care professionals; 4) Promoting new ways of preserving 
food in rural communities and consumption of fresh fruits and vegetables; 5) Encouraging 
patients to discuss their family history with healthcare providers to determine potential risks for 
inherited cancer syndromes.  
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Chapter 1: Introduction 
1.1 Gastric Cancer: A Public Health Problem 
Gastric cancer (GC), or cancer of the stomach or stomach cancer is categorized into two 
main classes: gastric cardia cancer (cancer of the top inch of the stomach, where it meets the 
esophagus) and non-cardia gastric cancer (cancer in all other areas of the stomach). Gastric 
cancer remains the fourth most common malignancy and the second most common cause of 
cancer-related deaths throughout the world (Jemal et al. 2011). Despite advances in surgical 
techniques, combined with neoadjuvant chemotherapy and radiotherapy approaches, gastric 
cancer continues to present a major clinical challenge, due to most cases being diagnosed in 
advanced stages with poor prognosis and limited options (Van Ness et al. 2012).  
The development of gastric cancer is recognized to be a complex and multifactorial 
process involving a number of etiological factors and multiple genetic and epigenetic alterations. 
According to the National Cancer Institute’s Surveillance, Epidemiology, and End Results 
(SEER) Program (2014), it is estimated that there will be 22,220 new cases of stomach cancer 
and an estimated 10,990 people will die of this chronic condition. Globally, gastric cancer caused 
the death of approximately 738,000 people worldwide in year 2008 (Ferlay et al., 2008) and most 
recently, the World Health Organization (WHO) estimated that gastric cancer caused the death of 
723,000 people worldwide in 2012 (WHO, 2012). Furthermore it is predicted that by 2030, 
gastric cancer will be the 10th leading cause of mortality worldwide (Mathers & Loncar, 2006).  
 In the United States, an estimated 21,600 new cases of gastric cancer were diagnosed in 
2013, and more than 10,000 people died of the disease (Shah & Enzinger, 2014). Previous 
studies on gastric cancer in Alaska have demonstrated that Alaska Native (AN) and American 
Indian (AI) populations are at a higher risk for gastric cancer than the general U.S. population 
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(Alberts et al. 2006). The higher incidence rate of gastric cancer in AN/AI populations is likely 
due to risk factors associated with Helicobacter pylori infection. In fact, AN/AI experience a 
seroprevalence of 75% (range: 61 to 84%, by region), making this rate of infection and stomach 
cancer rate higher than non-Native Alaskans (Wiggins et al., 2008). A study by the Centers for 
Disease Control and Prevention (CDC) Arctic Investigations Program (AIP) on H. pylori, 
endoscopic tissue biopsies were performed in Alaska. Results from the study show that 
antimicrobial resistance is more common in H. pylori isolates from AN/AI than in the U.S. 
population (Bruce et al., 2003). Furthermore, reinfection rates increase treatment failure to a 
current 35% for H. pylori Immunoglobulin G (IgG) antibody positivity with gastric cancer 
(McMahon et al., 2006). In developed nations, it is currently uncommon to find infected 
children; but the percentage of infected people increases with age, with about 50% infected for 
those over the age of 60 compared to around 10% between 18 and 30 years (WHO, 2012). The 
International Agency for Research on Cancer (IARC) estimates that 36 and 47% of all gastric 
cancer in developed and developing countries, respectively, are solely attributable to H. pylori 
infection. This accounts for almost 350,000 gastric cancers annually worldwide. One report 
indicated that of the 12.7 million new cancers occurring worldwide in 2008, a fraction or 16% is 
caused by H. pylori (de Martel et al., 2012).  
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Chapter 2: Background and Significance 
2.1 Background 
This study was conducted to provide an epidemiologic descriptive analysis of gastric 
cancer in Alaska, and to determine how it compares to the rest of the nation in terms of disease 
distribution and rates of gastric cancer. To compare the Alaska incidence rate to the U.S. 
statistics, the study presented a trend analysis of gastric cancer incidence rates in Alaska and the 
U.S. The trend analysis was important for the project because it is one leg above the analytic 
triangle of person, place, and time. Furthermore, it is also an important tool in public health 
surveillance, monitoring, forecasting, program evaluation, policy analysis, and etiologic analysis 
(investigation of potentially causal relationships between risk factors and outcomes) (Greenland, 
1995). 
Rates for Alaska populations are presented for comparison with focus on patient 
demographics (sex, race/ethnicity and age) as well as boroughs/census areas for a regional 
distribution and plot on annual incidence rate for a trend analysis of gastric cancer. When 
comparing gastric cancer incidence rates from one geographic area to another, a trend analysis is 
used to understand disease distribution. Other benefits to trend analysis include comparing 
subgroups to population over time to explore socioeconomic determinants that may explain 
disease burden to a particular subgroup. For instance, one population may have consistently 
higher rates over time compared to another population; and the rates in both populations may be 
decreasing over time, but the disparity between the rates in the two populations at each point in 
time may as well be increasing or decreasing. For this study, a univariate regression analysis of 
gastric cancer cases was carried out as another analysis because it presents several benefits over 
the other techniques like the chi-square test for trend.  
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In general, regression analysis has the advantage of jointly considering the information 
contained in the series of counts or rates, rather than considering each time point separately.  
Analyzing series of rates as a unit allows a comparison of incidence rate for each unit. Therefore, 
a regression analysis, as Siegal et al., (2007) indicate, imposes stability that allows narrowing the 
confidence limits calculated for each case count as opposed to group of cases for more powerful 
results.  
2.2 Predisposing Factors  
Gastric cancer has a number of etiological factors and multiple genetic and epigenetic 
alterations. Among the predisposing and/or influencing factors are: Helicobacter pylori infection, 
diet, environmental factors, and in a small percentage of patients a family genetic component 
(Sasako et al., 2010). 
2.2.1 Helicobacter Pylori Infection 
Helicobacter pylori, previously known as Campylobacter pylori, are micro-aerophilic 
spiral-shaped gram-negative bacteria that are found in the gastric mucous layer or adherent to the 
epithelial lining of the stomach. H. pylori infection is responsible for a considerable global 
burden, including peptic ulcer disease and gastric cancer (Blaser, 2006). Treatment and 
eradication of H. pylori infection remains a recommendation in patients with gastritis, and 
several studies have shown the benefit of anti-H. pylori treatment in reducing both the 
progression of precancerous lesions and the risk of gastric cancer (Correa et al., 2000). A study 
of mass eradication of H. pylori infection started in Taiwan, demonstrated a reduction of gastric 
atrophy but not intestinal metaplasia when compared with the five-year period before the study 
started (Lee et al., 2013). There also have been research studies on antimicrobial-resistant strains, 
not only for H. pylori but for other infectious agents. Some studies have suggested that since H. 
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pylori has been present in human beings since ancient times; strong arguments exist that consider 
the bacteria a part of the human gastric microbiome. Therefore, its elimination may cause an 
increase in prevalence of diseases such as gastroesophageal reflux, Barrett’s esophagus, and 
esophageal and cardia adenocarcinoma (Cover & Blaser, 2009).  
2.2.2 Dietary and Environmental Factors 
In regard to dietary and environmental factors, ecological studies were conducted to 
assess the importance of salt and nitrite intake at the population level in 24 countries (Joossens et 
al., 1996). The results from these studies show a significant correlation between gastric cancer 
mortality and sodium intake as well as nitrate intake in both men and women. Furthermore, the 
relationship between gastric cancer mortality and sodium was stronger than with nitrate. A 
similar study from Malaysia concluded that a high intake of salted fish was significantly 
associated with gastric cancer (Goh et al., 2007). Therefore, the consumption of salted food 
appears to increase the possibility of persistent gastric inflammation (Tsugane et al., 1994). In 
fact, a high salt diet may damage the gastric mucosal barrier, so the epithelial cells are more 
susceptible to contact with carcinogens such as nitroso compounds (Xiao et al., 1986). A study 
on dietary factors and assessing traditional food preservation in Turkey concluded that salt 
curing or smoking and lack of refrigeration of food play a significant role in gastric cancer 
development in study areas (Yalcin, 2009). The latter study also explored the underlying causes 
of differences in gastric cancer rates in regions of Turkey. The researcher found reasons for the 
differences to be nutritional such as high salt and nitrate consumption, poor food preparation and 
poor drinking water. In most affected regions, cooking is done in more traditional ways like 
salting and pickling; and for cooking, charcoal, wood, and dried cow dung is more often used as 
fuel. An analysis of bezo(a)pyrene (BP) and 1,2-benzanthrance (BA) levels in cooked foods, 
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especially in bread and meat consumed, were found to be high, indicating that bread and cooked 
meat are contaminated with BP and BA. Lastly, the study also showed the carcinogenic role of 
traditional foods baked or cooked using animal manure or fuel oil in the study regions (Turdogan 
et al., 2003).  
Unlike salt intake, several other prospective studies have reported significant reduction in 
gastric cancer risk arising from consumption of fresh fruits and vegetables. Evidence from these 
studies showed inverse association between fruit intake and gastric cancer incidence (Lunet et 
al., 2005). Fresh fruits and vegetables containing micronutrients are protective factors against 
gastric cancer and so there is a protective association with fresh fruits and vegetables and this 
association is independent of other dietary factors (Kono & Hirohata, 1996).  
Following migration of Japanese individuals to Hawaii, the rate of intestinal type cancers 
dropped by 50% indicating causal environmental factors while that of diffuse gastric cancer 
remained similar suggesting a stable hereditary component (Correa et al., 1973). In a study on 
nutrition and smoking interactions and their impact on gastric carcinogenesis, it was suggested 
that although gastric cancer is the result of a long multi-step and multifactorial process, there are 
potential interactions between H. pylori infection, environmental exposures and host genetic 
susceptibility (Gonzales & Agudo, 2012). In fact, positive associations between risk factors 
associated with smoking, environmental exposure and genetic susceptibility imply that, in certain 
subgroups of the population, the risk of gastric cancer will be higher than that in the rest of the 
population. As indicated in a study conducted in Japan, smoking causes oxidative stress and 
deoxyribonucleic acid (DNA) damage in smokers’ body, and active smokers have lower blood 
concentrations of ascorbic acid, alpha carotene, beta-carotene, which have been suggested as 
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explanations to why smokers benefit more from the consumption of fresh fruits and vegetables 
(Yuan et al., 2004). 
2.2.3 Genetic Predisposition 
Several studies on genetic predisposition reported that interleukin (IL)- 1β (-beta) gene 
polymorphism was closely related to the development of gastric cancer and that the risk of 
gastric cancer is two to ten times greater in subjects with a family history of the disease than in 
families without it (El-Omar et al., 2000). One of the studies on genetic predisposition suggested 
that (IL-1β) and Tumor Necrosis Factor-Alpha (TNF-α) gene clusters are consistent with gastric 
cancer predisposition; therefore, host genetic factors may determine why some individuals 
develop gastric cancer while others do not when exposed to the same gastric carcinogens (Zeng 
et al., 2002). In fact, the presence of cytokines and interleukin-1β (-beta) play a key role in the 
pathophysiology of gastric cancer and its role has been confirmed in animal models that mimic 
human gastric neoplasia (Robert et al., 1991). Another study on genetic predisposition indicated 
that the risk of gastric cancer is increased in first-degree relatives of patients with the disease by 
approximately two-to threefold. The most prominent study on gastric cancer and heredity is a 
Scandinavian Twin study of 44,788 pairs of twins in the Swedish, Danish, and Finnish twin 
registries that found an increased risk of gastric cancer in the twin of an affected person with 
gastric cancer (Lichtenstein et al., 2000). 
2.3 Interventions 
A meta-analysis that included seven controlled trials (all in areas with high incidence of 
gastric cancer) found significantly lower rates of gastric cancer (1.1 versus 1.7%) for those who 
were screened for H. pylori and received early treatment (Fuccio et al., 2009).  
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In Japan and South Korea, where gastric cancer is highly prevalent, national programs for 
mass screening and early detection have been implemented and the results of early screening and 
treatment show a significant decrease in gastric cancer incidence rate among these populations. 
In a case-controlled study from Japan, it shows 40 to 60% decreases in mortality from gastric 
cancer in those who have been screened and treated for early onset of the disease (Leung et al., 
2008).  
Incidence rates of stomach cancer have been declining steadily during the past fifty years 
in both developed and developing nations. It is believed that this decrease is largely due to 
several factors. These factors are the use of refrigerated foods, the availability of fresh fruits and 
vegetables, and a decrease in the use of salt as a means of preserving food. Other associated 
factors include a decrease in the prevalence of H. pylori infection in many countries and the 
decline of smoking in some industrialized countries as well (Jemal et al., 2011). A study in 
Shanghai urban districts shows that long-term use of home refrigerator was a protective factor 
against gastric cancer (Su & Shu, 2006). Similarly, many case-controlled studies have also 
shown that vitamins A, C, E and β-carotene can reduce the risk of gastric cancer. In fact, 
ascorbic acid, which is the reduced form of vitamin C, can react with nitrite and convert it to 
nitrous oxide, which is not carcinogenic (Azevedo et al., 1999). Furthermore, the consumption of 
fresh fruits and vegetables as well as dairy products, vitamin supplements, and drinking green tea 
were negatively related to gastric cancer. The greater the consumption of fresh fruits and 
vegetables, the merrier is the protection for gastric cancer (Su & Shu, 2006). Epidemiological 
and experimental studies have shown that bean products are also protective factors of gastric 
cancer because of the presence of isoflavone which is the dye genitein contained in the beans 
and, can prevent cancer (Kim et al., 2002). Lastly, it also was shown that green tea contains 
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plenty of antioxidants like polyphenols, vitamins C and E, which were consistent protective 
factors against gastric cancer (Yang et al., 1997). 
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Chapter 3: Project Goal and Objectives 
Although gastric cancer data have been collected from various hospitals across the state 
and out of state for Alaska residents, these have not been analyzed to determine the overall 
epidemiology of gastric cancer in Alaska. There had been published studies on the effect of H. 
pylori infection and the distribution of gastric cancer among AN/AI (McMahon et al., 2006); but 
no study had analyzed the epidemiology of gastric cancer in Alaska for all races/ethnicities. This 
study, therefore, bridged the gap by providing information to various stakeholders. 
The goal of this study was to provide a detailed epidemiologic descriptive analysis of 
gastric cancer to better inform health professionals, the public and provide additional resources 
for future research.  
In accomplishing this goal, the project objectives were the following:  
• To determine a regional distribution of gastric cancer,  
• To conduct a trend analysis of gastric cancer,  
• To identify and analyze disease case report demographics (race, age and sex) and  
• To compare the Alaska statistics to the national (U.S.) statistics.  
The purposes of this research were to provide information to populations, community 
partners and public health professionals. The study also has the potential for public health 
professionals to use results to daily healthcare practices in addition to provide information for 
high-risk populations, as well as epidemiological support for the prevention of gastritis leading to 
gastric cancer. 
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Chapter 4: Methods     
4.1 Study Population 
The population included in the study were annual cases of patients diagnosed with gastric 
cancer, all races (Whites, Blacks, AN/AI and Asians/Pacific Islanders) and ages from birth to 85 
years and older (Alaska Cancer Registry, 2014). For the purpose of calculating rates for patients 
with Asian and Pacific Islander origin, both the national database and Alaska condensed patient 
cases to a single entity of Asians/Pacific Islanders. Data used were annual cases reported to the 
Alaska Cancer Registry (ACR) from 1996 to 2011, while the U.S. statistics data were from 1999 
to 2011. All gastric cancer cases were from cases throughout the State of Alaska and from 
outside of the State of Alaska, so as long as the patient diagnosed was a resident of the State of 
Alaska. Several data items were collected and entered in both the national and the State of 
Alaska registry; however, for the purpose of the study, only aggregated data were reviewed, such 
as patients demographics (race/ethnicity, age and sex), and patients’ residence at the time of 
diagnosis.  
4.2 Data Source and Data Collection  
The study analyzed secondary data from ACR, which contained all reported cancer cases 
including gastric cancer from 1996 to 2011 (ACR, 2011). As a population-based cancer 
surveillance system that is funded by the Centers for Control Disease and Prevention (CDC), 
ACR have been collected data on all newly diagnosed cancer cases (including benign brain) for 
the State of Alaska. The registry operated under several statues and regulations required for 
compliance with Cancer Registries Amendment Act, Public Law (PL) 102-515; Alaska 
Administration Code 7 AAC 27.011-Reporting of cancer and brain tumors; and Alaska Statues 
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Sec. 18.05.042. The cancer registry’s overall purpose is to collect a wide variety of information 
to determine cancer incidence, mortality, treatment and survival rates.  
Data extracted from ACR included patient demographics (race/ethnicity, age and sex), 
year of diagnosis, and geographic location by borough and census area of reported cases as well 
as rates by years and case counts for statistical analyses and results. For this study, a research 
agreement was authorized between the principal investigator of the project and the community 
partner, from CDPHP, indicating the agency support of the research plan and its approval for 
data collection from ACR. The research letter of support is attached in the Appendix (See 
Appendix A).  
4.3 Protection of Human Research Subjects 
Permission to conduct the project while observing protection of human research subjects 
was requested through both UAA Institutional Review Board (IRB) and ACR. The investigator 
abided by the Health Insurance Portability and Accountability Act of 1996 (HIPAA) throughout 
the project. UAA IRB exempted this study because it did not involve human research subjects, 
rather it used secondary data analysis. An approval letter of exemption is provided in the 
appendix (See Appendix B). The process of seeking approval from an IRB is found in the Code 
of Federal Regulations for the protection of human research subjects (45 CFR 46), wherein UAA 
IRB was granted the authority to approve studies when they followed ethical guidelines, or 
disapprove research when they are concerns to human research subjects as covered by the 
University policy.  
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4.4 Data Analysis 
Data analysis methods included distribution by year/case counts for all races, Whites, 
AN/AI, distribution by race/ethnicity, age, borough/census area, race and sexes (male and 
female) for both Alaska and U.S., and a comparison by race/ethnicity for Alaska and U.S. When 
analyzing stomach cancer incidence rates by races/ethnicities in Alaska, the study calculated the 
upper and lower confidence intervals for all races as well as for each race separately.  
Univariate analysis modeling with linear regression was also carried out using the 
National Cancer Institute’s SEER*Stat (version 8.1.5 built March 26, 2014) statistical software 
in order to calculate the relevance of gastric cancer and its 95% confidence interval (95% CI) to 
both lower CI and upper CI.  
For the Alaska data, this study used ACR rates by year for all races/ethnicities combined 
as well as case counts from 1996 to 2011. The variables were transferred from ACR to the 
SEER*Stat statistical program to get both lower and upper confidence intervals for statistical 
tables that were later used to create graphics from Microsoft Excel software. When comparing 
the Alaska trend to the U.S. trend of gastric cancer, this study used U.S. statistics from the 
national SEER*Stat that combined data from the National Program of Cancer Registries and the 
National Cancer Institute’s SEER program for diagnosis years 1999 to 2011. U.S. statistics data 
included patients’ demographics (race/ethnicity, age and sex), year of diagnosis, case counts and 
residence. Cancer data from Alaska and the U.S. were formatted so that the SEER*Stat software 
could read and process them. These data provided a trend analysis and compared the Alaska 
incidence rates to the national rates. The practice of collecting information and attempting to spot 
a pattern, or trend is the hallmark of epidemiologic analysis in the way that it allows researchers 
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to understand that health outcomes in a population can only be fully understood if their 
frequency and distribution is examined in terms of person, place, and time (Rosenberg, 1997).   
When analyzing trend over the course of years, one may focus on the overall pattern of 
change in an indicator over time such as the years of disease diagnosis and whether there had 
been a significant increase or decrease over time (Rosenberg, 1997). The current study analyzed 
16 years of data from 1996 to 2011 collected by ACR. Therefore, it was meaningful to analyze 
annual rates for disease distribution and trends to spot a particular time from which the incidence 
rates were high or low in any given year and tried to determine the cause of the increased or 
decreased. The relevance of spotting a pattern or determining a trend is supported by the work of 
Rosenberg who thinks that the most general goal of trend analysis for public health surveillance 
is to discern whether the level of a health status, service, or systems indicator has increased or 
decreased over time, and if it had, how quickly or slowly the increased or decreased had occurred 
(Rosenberg, 1997). In fact, when comparing the level of an indicator across geographic areas, 
only looking at one point in time can be misleading. For instance, one geographic area may 
consistently have a higher value on an indicator in one year, but a lower value in the next; 
therefore, analyzing the trend over several years can give a more precise comparison of the two 
geographic areas and determine how they compared to one another. Upon analysis of both 
quantitative and qualitative data, results were presented to the public, community partners and 
health professionals in aggregated format. The results did not include any identifier to human 
research subjects such as name, social security number, and/or address. 
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Chapter 5: Results 
The study reviewed 587 cases of gastric cancer reported to ACR from 1996 to 2011 for 
the Alaska data and from 1999 to 2011 for the U.S. statistics. The national statistics were 
provided from the National Program of Cancer Registries database SEER program. A data 
analysis included a report of cases by year from 1996 to 2011 and annual cases by borough to 
determine a regional distribution as well as to conduct a trend analysis.  
Further analyses included rates distribution of patient demographics (race/ethnicity, age 
and sex) and comparing the Alaska rates to the national U.S. statistics. Furthermore, a trend 
analysis included rates by year for Alaska and U.S. statistics; and finally a comparison of annual 
incidence rates for AN/AI, Whites and all races combined. The study also conducted analyses by 
age from 00 to 85 years and older, boroughs/censuses areas for 32 boroughs as recognized by the 
2000 and 2010 censuses, sexes (male and female), and separately for male and female. Lastly, 
this study analyzed distribution by race/ethnicity for all races combined, as well as separately for 
Whites, Blacks, AN/AI and Asians/Pacific Islanders. 
5.1 Distribution by Year/Case Counts   
Overall, when analyzing Alaska rates, the study found that the trend of stomach cancer 
had decreased over time with a rate of (8.9 per 100,000) in 1996 to a rate of (7.2 per 100,000) in 
2011. The incidence rate for AN/AI had also varied over time; but it remained higher than other 
races. The study also found a variability and/or significant range when comparing rates from one 
race to another, which led to peaks when graphing for trend analysis. This variability was due to 
the fact that cases less than 20 per year are statistically unreliable and should therefore be used 
with caution when analyzing for trend. Figure 1 presents an analysis all races/ethnicities 
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combined, for Whites and AN/AI; while Table 1 shows annual rates and case counts all races 
combined in Alaska. 
Figure 1: Trend analysis for stomach cancer incidence rates all races/ethnicities: White, AN/AI, 
1996 to 2011. 
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Table 1: Stomach cancer incidence rates by year for all races/ethnicities combined: Alaska, 
1996 to 2011 
  All races       White       Black 
Alaska 
Native/AI 
Asian/Pacific 
Islander 
 Years Rate 
Case 
Counts Rate 
Case 
Counts Rate 
Case 
Counts Rate 
Case 
Counts Rate 
Case 
Counts 
1996 8.9 29 4.7 10 11 1 18 12 56 6 
1997 9 31 5.8 14 21 2 24 14 7.6 1 
1998 11.6 37 9.2 18 24 1 21 14 20 4 
1999 9.7 36 4.6 14 22 1 30 18 21 3 
2000 10.7 38 6.5 17 12 1 26 14 26 6 
2001 9 33 7 22 18 1 17 9 15 1 
2002 10.6 39 5.3 15 0 0 40 22 10 2 
2003 7.3 30 4.8 16 18 2 15 9 14 3 
2004 7 32 4 14 12 1 24 16 4.6 1 
2005 6.9 36 4.2 18 4.2 1 22 16 5.8 1 
2006 6.3 30 3.9 13 0 0 16 14 17 3 
2007 7.7 38 3.3 13 3.8 1 31 22 10 2 
2008 9.9 48 6.8 24 0 0 18 15 34 9 
2009 5.9 35 4.6 21 3.4 1 15 12 2 1 
2010 8.6 48 5.8 24 3.3 1 23 19 11 4 
2011 7.2 47 5.3 23 7 2 15 16 9.3 5 
Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard Population (19 age groups-
Census P25-1130).  
W: White    B/A: Black   AN: Alaska Native   A/PI: Asian/Pacific Islander        
 
5.2 Distribution by Race/Ethnicity 
When analyzing by race/ethnicity, the study determined and compared rates for all races, 
as well as Whites, Blacks, AN/AI and Asians/Pacific Islanders. From the analysis, the study 
presented most affected races with the potential to focusing on prevention measures and/or 
culturally health education tools to be applied to at risk-groups. The study found that rates in 
Alaska were significantly distributed with higher incidence for AN/AI (22.1 per 100,000) as 
opposed to Blacks (8.9 per 100,000); Whites (5.2 per 100,000) and Asians/Pacific Islanders (14.8 
per 100,000). All rates of gastric cancer are per 100,000 populations age-adjusted to the 2000 
U.S. standard population. In addition, the study also found that Asians/Pacific Islanders were the 
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second racially group most affected with a rate of 14.8 cases per 100,000 populations. The 
incidence rates by race/ethnicity in Alaska from 1996 to 2011 for the study population are shown 
in Table 2 while Figure 2 shows incidence rates by race/ethnicity in Alaska from 1996 to 2011. 
Table 2: Stomach cancer incidence rates by race/ethnicity: Alaska, 1996 to 2011  
 
 
 
 
 
 
 
Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard population (19 age groups - 
Census P25-1130) standard; confidence intervals (Tiwari mod) are 95% for rates. 
 
 
  
 Figure 2: Stomach cancer incidence rates by race/ethnicity: Alaska, 1996 to 2011. 
 
 
  
               
Rate 
  
Lower CI Upper CI Count 
All races 8.3 7.6 9.1 587 
White 5.2 4.6 5.9 276 
Black 8.9 4.7 15 16 
Alaska Native 22.1 19.2 25.2 242 
Asian/Pacific Islander 14.8 10.7 19.7 52 
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5.3 Distribution by Age 
The analysis of rates by age all races combined included patient’s ages from 0 to 85 years 
and older. The study found that age is significantly related to disease. No cases were reported 
between 0 to 14 years and double were the rates at age 65 years with a much greater increase at 
age 75 years and older.   
To conduct a trend analysis by age and all races/ethnicities combined, the study presented 
in Table 3 the age distribution by years, rates, case counts as well as lower and upper confidence 
intervals for each age category. Figure 3 shows a graphic representation by age and all 
races/ethnicities combined.  
Table 3: Univariate regression analysis of stomach cancer incidence rates by age and all 
races/ethnicities: Alaska (n=587) 
 
 
 
 
All races 
  Rates Lower CI Upper CI Case Counts 
Age Group (years) 8.3 7.6 9.1 587 
00-04 0.0 0.0 0.5 0 
05-09 0.0 0.0 0.5 0 
10-14 0.0 0.0 0.4 0 
15-19 0.2 0.0 0.9 2 
20-24 0.3 0.0 0.9 2 
25-29 0.6 0.2 1.4 4 
30-34 1.3 0.6 2.4 10 
35-39 2.7 1.7 4.1 22 
40-44 2.2 1.3 3.4 19 
45-49 6.9 5.3 8.9 60 
50-54 5.8 4.2 7.7 44 
55-59 11.9 9.2 15.0 69 
60-64 15.1 11.5 19.5 59 
65-69 38.4 31.1 46.8 97 
70-74 39.4 30.6 49.8 69 
75-75 54.1 41.9 68.9 66 
80-84 46.1 31.5 64.4 34 
85+ years 55.5 37.5 79.3 30 
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Figure 3: Stomach cancer incidence rates by age: Alaska, 1996 to 2011. 
 
5.4 Distribution by Borough/Census Area 
The distribution by borough/census area analyzed 32 boroughs/censuses areas as 
recognized by the U.S. census of 2010. In this regard, the study found that the Municipality of 
Anchorage had the highest case counts with 218 cases; Matanuska-Susitna borough had 43 cases 
and Fairbanks North Star borough had 42 cases. The highest incidence rates were attributed to 
Prince of Wales-Hyder Census area (39.2 per 100,000); Northwest Arctic Borough (37.3 per 
100,000); North Slope Borough (36 per 100,000); Bethel census area (26.6 per 100,000) and 
Wade Hampton census area (26.5 per 100,000). Table 4 shows the incidence rates by 
borough/census area while Figure 4 shows the incidence rates by borough/census from the same 
year as well.  
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Table 4: Stomach cancer incidence rates and case counts by borough/census area:     
Alaska, 1996 to 2011              
Boroughs/Census Areas Incidence 
Rates 
Case Counts 
Prince of Wales-Hyder Census Area (PWHCA) 39.2 2 
Northwest Arctic Borough (NWAB) 37.3 29 
North Slope Borough (NSB) 36.0 24 
Bethel Census Area (BCA) 26.6 38 
Wade Hampton Census Area (WHCA) 26.5 16 
Nome Census Area (NCA) 24.5 24 
Yakutat Borough (YB) 23.1 2 
Yukon-Koyukuk Census Area (YKCA) 20.3 18 
Lake Peninsula Borough (LPB) 18.8 4 
Aleutians West Census Area (AWCA) 14.2 3 
Kodiak Island Borough (KIB) 12.8 11 
Skagway-Hoonah-Angoon Census Area (SHACA) 10.5 6 
Prince of Wales-Outer Ketchikan Census (PWOKC) 10.2 7 
Wrangell-Petersburg Census Area (WPCA) 8.9 8 
Municipality of Anchorage (MOA) 8.1 218 
Dillingham Census Area (DCA) 7.9 5 
Valdez-Cordova Census Area (VCCA) 7.3 8 
Ketchikan Gateway Borough (KGB) 6.5 11 
Juneau Borough (JB) 5.6 22 
Kenai Peninsula Borough (KPB) 5.3 35 
Matanuska-Susitna Borough (MSB) 5.1 43 
Fairbanks North Star Borough (FNSB) 4.8 42 
Bristol Bay Borough (BBB) 4.3 1 
Haines Borough (HB) 4.3 2 
Aleutians East Borough (AEB) 3.7 2 
Southeast Fairbanks Borough (SFB) 3.6 4 
Sitka Borough (SB) 1.9 2 
Denali Borough (DB) 0 0 
Hoonah-Angoon Census Area (HACA) 0 0 
Petersburg Census Area (PCA) 0 0 
Skagway Municipality (SM) 0 0 
Wrangell Borough (WB) 0 0 
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Figure 4: Stomach cancer incidence rates by borough/census area: Alaska, 1996 to 2011. 
 
 
Also, out of the 32 boroughs/censuses areas in Alaska, 9 of these had higher rates and Figure 5 
shows a map by boroughs/censuses areas. 
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Figure 5: Stomach cancer incidence map: Alaska, 1996 to 2011. Map created in MapInfo 
Professional version 12.5 by David O’Brien, PhD, GISP.  
 
5.5 Distribution by Race/Ethnicity and Sex 
In the analysis by race/ethnicity and sex, the study used data for both sexes (male and 
female) as well as separately for males and females to provide incidence rates for each aggregate.  
In Alaska, the disease distribution by race/ethnicity and sex indicated that for all 
races/ethnicities combined, the males’ incidence (11.6 per 100,000) is twice as high as the 
females’ incidence (5.4 per 100,000). The study also examined incidence rates for Alaska 
Natives in Southeast (SE) Alaska versus non-SE Alaska. The incidence rates of the two groups 
indicated that SE Alaska Natives had a much high incidence rates as compared to non-SE Alaska 
Natives.  
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  The White males’ incidence rate (7.6 cases per 100,000) was two times higher than the 
White females’ incidence rate (2.9 per 100,000). In addition, the Black males incidence rate 
(15.7 per 100,000) was five time higher than the Black females incidence rate (3.2 per 100,000). 
The AN/AI incidence rate (29.6 per 100,000) was higher in males than in females (16.5 per 
100,000). Lastly, the Asians/Pacific Islanders incidence rate (25.8 per 100,000) was three times 
higher in males than it was in females (8.2 per 100,000). Figure 6 shows incidence rates by 
race/ethnicity and sex (male and female) in Alaska. 
Figure 6: Stomach cancer incidence rates by race/ethnicity and sexes (male and female): Alaska, 
1996 to 2011. 
 
In the U.S. statistics, the distribution by sex for all races/ethnicities combined indicated 
that the incidence rate for males was twice as high as the incidence rate for females. The 
incidence rate for males was (9.83 per 100,000) while the incidence rate for females was (4.81 
per 100,000). White males had an incidence rate of (8.88 per 100,000) which was twice as high 
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as the incidence rate for White females (4.17 per 100,000). In addition, Black males incidence 
rate (6.88 per 100,000) was also twice as high as the incidence rate for Black females (8.52 per 
100,000).  
The incidence rate for AN/AI males (9.44 per 100,000) was twice as high as the 
incidence rate for AN/AI females (4.95 per 100,000). Lastly, the Asians/Pacific Islanders males’ 
rate (16.91 per 100,000) was also twice as high as the Asians/Pacific Islanders females’ rate 
(9.58 per 100,000) population. Figure 7 shows incidence rates by race/ethnicity and sexes (male 
and female), in the U.S. from 1999 to 2011. 
Figure 7: Stomach cancer incidence rates by race/ethnicity and sexes (male and female): U.S. 
1999 to 2011. 
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5.6 Distribution by Race/Ethnicity Alaska and U.S. 
The rates distribution by race/ethnicity in Alaska and its comparison with the U.S. 
statistics included an analysis of the following: combined races/ethnicities (Whites, Blacks, 
AN/AI, Asians/Pacific Islanders) and separately for each one of the races/ethnicities mentioned 
above. 
When comparing incidence rates for Alaska and the U.S. incidence rates, this study found 
that rates in Alaska, all races/ethnicities combined, were higher than national rates. During the 
stated periods of time, incidence rates for AN/AI were three times the national rates. Figure 8 
shows rates for all races in Alaska from 1996 to 2011 and from 1999 to 2011 for the U.S. 
statistics. Rates for American Indians living in the continental U.S. were much lower than Alaska 
Natives living in Alaska; and that the incidence rates for U.S. Asians living in the continental 
U.S. were also much lower than Asians living in Alaska. Figure 8 shows the incidence rates by 
races/ethnicities for Alaska and the U.S. 
Figure 8: Stomach cancer incidence rates by races/ethnicities: Alaska, 1996 to 2011 and U.S. 
1999 to 2011. 
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Chapter 6: Discussion 
The study results on gastric cancer, the first large scale study that provided a descriptive 
analysis of the disease with the potential to inform health professionals, the public and resources 
for future research was consistent with the already great number of gender difference in cancer 
studies. This study analyzed 16 years of data collected by ACR and 12 years of data for the U.S. 
statistics for comparison to Alaska rates and U.S. incidence rates. Overall, stomach cancer 
incidence rates in Alaska had decreased over the course of the study years from a rate of (8.9 per 
100,000) in 1996 to a rate of (7.2 per 100,000) in 2011. Despite the decrease, there were higher 
rates in 1998 with (11.6 per 100,000); and 2002 with (10.6 per 100,000); and incidence rates also 
fluctuated over the years with the lowest rates (6.3 per 100,000) in 2006. The study also found 
that incidence rates were higher in Blacks as opposed to Whites and Asians/Pacific Islanders. 
Alaska Natives, continued to have the highest rates compared to others races/ethnicities (Whites, 
Blacks and Asians/Pacific Islanders).  Age was significantly related to disease all races combined 
with increasing rates at age 70 years and older. The older a person was, the more likely he or she 
developed gastric cancer. Older adults risk was twice the risk for younger adults and none to 
children. The study also found that in Alaska, males were twice at risk as females and that rate 
for Alaska Native males and Asians/Pacific Islanders males was much higher than males from 
other races/ethnicities. Alaska Natives living in Alaska had a higher incidence rates than 
American Indians living in the continental U.S. Moreover, SE Alaska Natives incidence rates 
were also higher than non-SE Alaska Natives. The rates for Asians/Pacific Islanders males were 
also twice as high as the rates for Asians/Pacific Islanders females. In addition, Asians/Pacific 
Islanders from the continental U.S. rates were higher than Asians/Pacific Islanders living in 
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Alaska. The disease distribution by boroughs/censuses areas found a higher incidence rates for 
boroughs that were mostly populated by Alaska Natives.  
In Alaska, the disease distribution by race/ethnicity and sexes (male and female) 
indicated that for all races combined, the males’ rates were twice as high as the females’ rates. In 
the U.S. statistics, the distribution by sex for all races/ethnicities combined indicated that the rate 
for males was twice as higher as females. When the Alaska incidence rates were compared to the 
U.S. statistics, the study found that although the rates had decreased over time for Alaska, as 
indicated earlier, they remained higher than national incidence rates. 
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Chapter 7: Strengths and Limitations 
7.1 Strengths 
Strength of this study was the access to the database from ACR. This study analyzed 16 
years of data collected by ACR included all reported cases of gastric cancer. The Alaska Cancer 
Registry had been in place since January 1996 and was enacted by state regulations (7 AAC 
27.011) that established reporting requirements for statewide cancer registry. As a population- 
based registry, ACR recorded all cancer cases diagnosed and treated in Alaska since 1996. 
ACR’s purpose was to identify all reportable cases of cancer in Alaska in order to provide 
information on the burden of cancer, types of cancer, and changing patterns of cancer among 
residents of Alaska. Hospitals, outpatient centers, free-standing pathology or diagnostic 
laboratories, physicians, home health agencies, hospices, nursing homes and intermediate care 
facilities are all required to report cancer cases to ACR. When cancer cases are diagnosed, the 
timeframe for reporting it to ACR was within 6 months of initial diagnosis. If the cancer 
diagnosis was made prior to the patient being seen at that facility, the reporting timeframe was 
within 6 months from the patient’s first visit to that facility. The cancer registry collected over 
400 data items that included: patient identifiers (name, date of birth, gender, race/ethnicity, social 
security number, residence, zip code, place of birth, marital status, age at time of diagnosis and 
medical record number), cancer diagnosis information, and cancer treatment information. 
Second, this study analyzed patient demographics for consistency with the objectives to provide 
incidence rates distribution by year for all races/ethnicities ages and sexes. Third, the distribution 
of gastric cancer rates correlated to the overall geographic distribution of Alaska population by 
race/ethnicity for boroughs and/or censuses areas. For example, many of the borough/census 
areas had a high concentration of Natives, while others had a high concentration of Whites and 
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regions with high populations of Natives also had high incidence rates. Another was that ACR 
data were annually certified by the North American Association of Central Cancer Registries 
(NAACCR), whereas the high quality and the completeness required under the Gold 
Certification requirements. Lastly, ACR data had continuously undergone quality assurance 
reviews for data accuracy. ACR data were reviewed by NAACCR and certified to be over 95% 
complete. 
7.2 Limitations   
When rates for Alaska and the U.S. where compared, the study considered U.S. statistics 
from 1999 to 2011. Gastric cancer data from 1999 to 2011 reported by the National Program of 
Cancer Registries (NPCR) represented at least 95% completeness of data, whereas data prior to 
1999 were not validated due to confounders and bias. Second, cancer incidence data were based 
on patient data reported to ACR from a variety of sources, including hospitals, physicians, 
pathology laboratories, and other cancer registries, as per public health reporting laws. If a 
healthcare provider did not report a cancer patient and that patient was not seen by any other 
healthcare provider, then that patient was not in ACR database. Another was that, incidence and 
mortality rates were based on calculations using Alaska population data by borough and census 
area. These data were originally from the U.S. Census Bureau, compiled by the National Center 
for Health Statistics, and provided to ACR by the National Cancer Institute’s SEER program. 
The population data were as accurate as the information provided to the U.S. Census Bureau. 
Lastly, healthcare statistics such as cancer rates were not exact figures. The actual figure might 
had been slightly higher or slightly lower, and there could had been a calculation of what the 
range was in the form of a “confidence interval”. Therefore, the size of the confidence interval 
depended on the population of the group being evaluated. The larger the group, the smaller the 
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confidence interval, and the more precise the statistic was. The population of the entire state of 
Alaska would have had a relatively small confidence interval compared to that of a rural village. 
Lastly, other studies on the subject could look at the difference in rates between Alaska and the 
U.S. and/or the disparity male/female. Further studies could also evaluate the difference within 
Alaska for AN/AI living in southeast versus AN/AI living in southwest and/or the efficacy of 
health programs and campaigns that addressed predisposing factors for at risk-groups.  
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Chapter 8: Public Health Implications 
Gastric cancer or stomach cancer had been a public health concern to both the Alaska 
Native Tribal Health Consortium through its Alaska Native Epidemiology Center and the State 
of Alaska Department of Health and Social Services through its Division of Public Health - 
Section of Chronic Disease Prevention and Health Promotion.  
This study had the potential to support and promote disease surveillance because public 
health professionals and other community partners were able to report data to the Alaska Cancer 
Registry. It also had the potential for epidemiologists to be informed on the pattern and 
progression of the disease for surveillance. In addition, this study had the potential to affect 
populations and public health professionals because they could use results for culturally health 
education campaigns to at risk-groups in the communities they practice. Similarly, results could 
be published with the Section of Chronic Disease Prevention and Health Promotion as well as 
the Epidemiology Bulletin in the Section of Epidemiology and/or the Alaska Native 
Epidemiology Center for dissemination of this epidemiological information for use by other 
public health professionals.  
In addition to the public health implications at the local level (State of Alaska, 
community partners, populations and stakeholders), this study addressed three out of the ten 
Essential Public Health Services (EPHS) outlined by CDC (2010). First, “to diagnose and 
investigate health problems and health hazards in the community” (EPHS#2) by using data from 
the Alaska Cancer Registry to examine the burden of gastric cancer in Alaska as well as 
determining how Alaska compared to the rest of the nation in term of rate of infection. Second, 
“to inform, educate, and empower people about health issues (EPHS#3). Results from the study 
could provide information to the public, future researchers and public health professionals to use 
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for themselves or in their daily practices. Lastly, “to research for new insights and innovative 
solutions to health problems” (EPHS#10). This included using approaches such as genetic 
screenings for early detection and treatment as well as mass detection in at-risk-populations. 
Empowering at risk-groups to discuss to health care providers and others genetic specialists 
about family history of the disease could lead to early intervention and longitudinal studies to 
determine those who developed gastric cancer. 
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Chapter 9: Conclusion and Recommendations 
9.1 Conclusion 
This study concludes that stomach cancer has continued to be a burden in Alaska for all 
races/ethnicities combined with a greater incidence in AN/AI populations. Additionally, across 
races/ethnicities, the older a person was, the more likely he or she was at risk. Moreover, males 
were significantly at risk to being diagnosed than females. The incidence rate for males was two 
times the rate for females. Alaska incidence rates were significantly higher than national rates. 
When analyzing boroughs/censuses areas data, this study concluded that boroughs/censuses 
areas with higher incidence rates were mostly-populated by AN/AI. Within Alaska, there also 
were differences in incidence rates for AN/I living in southeast versus AN/AI living in southwest 
Alaska. The incidence rates for Asians/Pacific Islanders were also significantly higher than the 
Whites and the Blacks. As referenced in the literature, a diet rich in fresh fruits and vegetables 
significantly reduced gastric cancer risk (Kobayashi et al., 2002). In fact, a diet rich in fresh 
fruits and vegetables was a protective effect against gastric cancer because of ascorbic acid, 
carotenoid and beta-carotene. Ascorbic acid is an anti-oxidant that significantly reduces mitotic 
activity in tumor cells without disturbing the growth of normal cells (Poydock et al., 1979). 
As indicated in the literature, this study did not look at cases that were solely due to H. 
pylori infection, diet and/or environmental factors as well as genetic predisposition. Future 
research can analyze the impact of each one of the aforementioned factors and their contribution 
to gastritis leading to gastric cancer. Other studies can also look at males and females incidence 
rates; the difference within Alaska, the reasons why borough/census areas mostly affected were 
populated by AN/AI. Future studies can also explore the difference between Asians/Pacific 
Islanders living in the continental U.S. with those living in Alaska and perhaps evaluating 
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education campaigns that have been in place to promote early screening, detection and treatment. 
Lastly, studies can also look at challenges to lifestyle in rural Alaska and factors related to 
subsistence food and the lack of health care services in rural communities. 
9.2 Recommendations  
Based on the study analyses and the literature, the following recommendations are 
suggested in order to reduce the burden of gastric cancer in Alaska.  
Recommendation #1:  
Health education campaigns for at risk-groups 
Promoting health education campaigns for at risk-groups will mean cultural sensitivity 
when designing and implementing programs to these groups. The cultural difference between 
AN/AI populations from each borough does not allow for a “one size fits all” campaign. Because 
AN/AI living in southwest Alaska have different practices than AN/AI living in southeast; it will 
be important to design health education campaigns that are specific to each area. By educating at 
risk-groups, there is the potential to empower them to take charge of their health by closely 
monitoring their healthcare status and allowing them to act as peer support to other individuals in 
the community.  
Recommendation #2: 
Making health care services available  
Alaska health care system is scarce with a presence of major hospitals in hub areas and in 
cities with larger population. This makes rural communities and populations living in these 
communities more vulnerable. To improve preventive care, it may be valuable to encourage at-
risk groups to have checkups at their local clinic. If the budget allows, public health 
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professionals can travel to these isolated rural communities for screening and establishing 
follow-up to at risk-populations with community health aid workers. 
Recommendation #3: 
Education of local health community workers and health care professionals 
  By providing results from this study, there is the potential to inform and educate local 
health community workers and health professionals to use them to their daily practices. These 
health professionals will be able to discuss to at risk-groups they served about disease risk -
factors, interventions, early screening, early detection and early treatment. 
Recommendation #4 
Promoting new ways of preserving food in rural communities and consumption of fresh 
fruits and vegetables 
In rural communities, food are often preserved by salt and based on the literature, sodium 
and nitrate significantly damage stomach mucosal biome which increases the risk for other 
gastric diseases like Barrett’s disease and gastritis. This study therefore recommends preserving 
foods by smoking or using refrigeration as a way of conservation. However, this 
recommendation can challenging to rural communities of the cultural ties of preserving food and 
related expenses to fuel consumption and energy rate. Another challenge is the availability of 
fresh fruits and vegetables all year long. As a circumpolar area, a long winter season makes it 
harder for communities to grow and produce fresh fruits and vegetables for their populations. 
Substituting canned fruits and canned vegetables with fresh fruits and vegetables may be 
expensive in the long term for at-risk groups.  
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Recommendation #5:  
Encouraging patients to discuss their family history with healthcare providers determine 
potential risks for inherited cancer syndromes.  
 As referenced early in the literature review, patients with family history of gastric cancer 
and those with certain polymorphism might be at greater risk of the disease. Therefore, 
discussing with a genetics professional about genetic testing may be helpful for patients to take 
appropriate steps toward early detection and treatment if testing results show a mutation or 
abnormal change.   
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Appendix C 
 
 
Race alone White Black AN/AI Asian Pacific 
Islander 
Other 
Prince of Wales-Hyder Census Area 2,799 17 2,207 21 21 20 
Northwest Arctic Borough    846 37 6,121 42 12 17 
North Slope Borough 3,147 94 5,100 425 104 67 
Bethel Census Area 1,894 65 14,109 160 27 45 
Wade Hampton Census Area    201   1   7,085 18   0   3 
Nome Census Area 1,552 27   7,199 96   9 22 
Yakutat Borough    281   2      237 27 12   1 
Yukon-Koyukuk Census Area 1,243 10   3,992 14   6   9 
Lake Peninsula Borough    380   9   1,061   6   5   6 
Census data from the Alaska Department of Labor (2010). Retrieved from 
http://live.laborstats.alaska.gov/cen/dparea.cfm 
  
 
 
 
 
 
 
 
